PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Photrexa Viscous In Dextran 20%/photrexa, and what generic alternatives are available?
Photrexa Viscous In Dextran 20%/photrexa is a drug marketed by Glaukos and is included in one NDA.
The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA?
- What are the global sales for PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA?
- What is Average Wholesale Price for PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA?
Summary for PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
US Patents and Regulatory Information for PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA | riboflavin 5'-phosphate sodium | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
